Skip to main content
Premium Trial:

Request an Annual Quote

Insider Tips on Selling into the Japanese Bioinformatics Market

Premium

• Keep in mind that the sales cycle is generally longer in Japan than in the US and Europe. Companies make their purchasing decisions prior to the budgeting process rather than afterwards.

• Building trust and credibility is crucial to success in the Japanese market. Customers tend to consider vendor-buyer relationships more as partnerships than in the US and Europe, so a customer-centric strategy is a necessity.

• Japanese technology buyers place a higher value on product quality than customers in the US or Europe. Service contracts are often perceived as a sign of a faulty product and are difficult to sell.

• Any product documentation that you can provide in the Japanese language is a plus.

• It’s a good idea to use a distributor when first selling into the Japanese market. Look for companies with strong domain knowledge, a solid customer base, and a business strategy in line with your own.

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.